Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy

References

• Arroyo AG, Yang JT, Rayburn H, Hynes RO (1996). Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell 85: 997–1008.
   PubMed Web of Science ®Google Scholar
• Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R (1986). Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 315: 230–234.
   PubMed Web of Science ®Google Scholar
• Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Khoo SH (2004). Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol 29: 224–229.
   PubMed Web of Science ®Google Scholar
• Bonig H, Wundes A, Chang KH, Lucas S, Papayannopoulou T (2008). Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood 111: 3439–3441.
   PubMed Web of Science ®Google Scholar
• Carr MJ, McCormack GP, Mutton KJ, Crowley B (2006). Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recipients with and without hemorrhagic cystitis. J Med Virol 78: 485–493.
   Google Scholar
• Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, Woodle ES, Khalili K, Koralnik IJ. (2006). Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 80: 3495–505.
   PubMed Web of Science ®Google Scholar
• Comoli P, Binggeli S, Ginevri F, Hirsch HH. (2006). Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 8: 86–94.
   PubMed Web of Science ®Google Scholar
• Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009). Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199: 837–846.
   PubMed Web of Science ®Google Scholar
• FDA (2008). Natalizumab (marketed as Tysabri) Information.
   Google Scholar
• Gardner SD, Field AM, Coleman DV, Hulme B (1971). New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1: 1253–1257.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Mohaupt M, Klimkait T (2001). Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 184: 1494–1495.
   PubMed Web of Science ®Google Scholar
• Ikegaya H, Saukko PJ, Tertti R, Metsarinne KP, Carr MJ, Crowley B, Sakurada K, Zheng HY, Kitamura T, Yogo Y (2006). Identification of a genomic subgroup of BK polyomavirus spread in European populations. J Gen Virol 87: 3201–3208.
   Google Scholar
• Kalvatchev Z, Slavov S, Shtereva M, Savova S (2008). Reactivation of Polyomavirus hominis 1 (BKV) during pregnancy and the risk of mother-to-child transmission. J Clin Virol 43: 328–329.
   Google Scholar
• Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB (2007). Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 6: 431–441.
   PubMed Web of Science ®Google Scholar
• Khalili K, White MK, Lublin F, Ferrante P, Berger JR (2007). Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 68: 985–990.
   PubMed Web of Science ®Google Scholar
• Knowles WA (2002). The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: Human polyomaviruses: molecular and clinical perspectives. Khalili K, Stoner GL (eds). New York: Wiley-Liss, pp 527–558.
   Google Scholar
• Kurtzke JF (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS (1993). Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 167: 13–20.
   Google Scholar
• Nishimoto Y, Zheng HY, Zhong S, Ikegaya H, Chen Q, Sugimoto C, Kitamura T, Yogo Y (2007). An Asian origin for subtype IV BK virus based on phylogenetic analysis. J Mol Evol 65: 103–111.
   Google Scholar
• Polo C, Perez JL, Mielnichuck A, Fedele CG, Niubo J, Tenorio A (2004). Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 10: 640–644.
   Google Scholar
• Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S (2008). Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation 85: 185–192.
   Google Scholar
• Ransohoff RM (2005). Natalizumab and PML. Nat Neurosci 8: 1275.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM (2007). “Thinking without thinking” about natalizumab and PML. J Neurol Sci 259: 50–52.
   Google Scholar
• Reploeg MD, Storch GA, Clifford DB (2001). Bk virus: a clinical review. Clin Infect Dis 33: 191–202.
   PubMed Web of Science ®Google Scholar
• Rodrigues C, Pinto D, Medeiros R (2007). Molecular epidemiology characterization of the urinary excretion of polyomavirus in healthy individuals from Portugal—a Southern European population. J Med Virol 79: 1194–1198.
   Google Scholar
• Rosen S, Harmon W, Krensky AM, Edelson PJ, Padgett BL, Grinnell BW, Rubino MJ, Walker DL (1983). Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 308: 1192–1196.
   PubMed Web of Science ®Google Scholar
• Sabath BF, Major EO (2002). Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis 186 (Suppl 2): S180–S186.
   Google Scholar
• Schaffer K, Sheehy N, Coughlan S, Bergin C, Hall WW (2006). JC virus in the Irish population: significant increase of genotype 2 in immunocompromised individuals. J NeuroVirol 12: 39–46.
   Web of Science ®Google Scholar
• Stuve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand'Maison F, Hemmer B, Monson NL, Racke MK (2006). Altered CD4 + /CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 63: 1383–1387.
   PubMed Web of Science ®Google Scholar
• Sundsfjord A, Flaegstad T, Flo R, Spein AR, Pedersen M, Permin H, Julsrud J, Traavik T (1994). BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 169: 485–490.
   Google Scholar
• Whiley DM, Mackay IM, Sloots TP (2001). Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J Clin Microbiol 39: 4357–4361.
   PubMed Web of Science ®Google Scholar
• Wong AS, Chan KH, Cheng VC, Yuen KY, Kwong YL, Leung AY (2007). Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 44: 830–837.
   Google Scholar
• Yao K, Gagnon S, Akhyani N, Williams E, Fotheringham J, Frohman E, Stuve O, Monson N, Racke MK, Jacobson S (2008). Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. PLoS ONE 3: e2028.
   Web of Science ®Google Scholar
• Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jager HR, Clifford DB (2006). Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354: 924–933.
   PubMed Web of Science ®Google Scholar
• Zhong S, Randhawa PS, Ikegaya H, Chen Q, Zheng HY, Suzuki M, Takeuchi T, Shibuya A, Kitamura T, Yogo Y (2009). Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol 90: 144–152.
   PubMed Web of Science ®Google Scholar
• Zhong S, Zheng HY, Suzuki M, Chen Q, Ikegaya H, Aoki N, Usuku S, Kobayashi N, Nukuzuma S, Yasuda Y, Kuniyoshi N, Yogo Y, Kitamura T (2007). Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J Clin Microbiol 45: 193–198.
   PubMed Web of Science ®Google Scholar
• Zohren F, Toutzaris D, Klärner V, Hartung HP, Kieseier B, Haas R (2008). The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood 111: 3893–3895.
   PubMed Web of Science ®Google Scholar